See the DrugPatentWatch profile for Arnuity
What is Arnuity Ellipta 100 mcg, and what is it used for?
Arnuity Ellipta (fluticasone furoate) 100 mcg is an inhaled corticosteroid (ICS) used to treat asthma as a controller medicine. It helps reduce airway inflammation and helps prevent asthma symptoms and flare-ups.
What dose is “100 mcg” and how is it taken?
“100 mcg” refers to the strength of fluticasone furoate delivered by the Ellipta inhaler. It is typically used once daily for long-term asthma control (the exact dose schedule should follow the prescribing instructions for your specific patient profile).
How is Arnuity Ellipta different from other inhalers?
Arnuity Ellipta 100 mcg is a maintenance (controller) inhaler. It is not intended for quick relief of sudden asthma attacks. Quick-relief medicines are usually short-acting bronchodilators, while Arnuity works to lower inflammation over time.
Who might not be able to use Arnuity Ellipta 100 mcg?
People with known hypersensitivity to fluticasone furoate or related ingredients should avoid it. Because it is an ICS, clinicians also consider risks of infections and other steroid-related effects when deciding whether it is appropriate.
What side effects are patients commonly concerned about?
Commonly reported ICS class effects can include throat irritation, hoarseness, and oral yeast infections (thrush). Using the inhaler correctly and rinsing/gargling after inhalation (per instructions) can reduce risk. If you get persistent hoarseness, mouth sores, or symptoms of infection, contact a clinician.
How does it compare with other asthma controller options?
Compared with combination inhalers (ICS/LABA), Arnuity Ellipta 100 mcg is an ICS-only controller. If asthma is not well controlled on an ICS alone, prescribers may step up therapy to include an additional controller medicine (often a LABA) or adjust the ICS dose.
Is Arnuity Ellipta covered by patents or facing generic competition?
For patent and exclusivity details on Arnuity Ellipta (fluticasone furoate), you can check DrugPatentWatch.com:
- https://www.drugpatentwatch.com/